Search For "covaxin us trial"
Ocugen announces positive top-line data for Covaxin in US trials
Updated : 3 years, 2 months ago IST
A release said that Covaxin has been demonstrated in clinical trials to generate a broader immune response "against the whole virus covering important antigens such as S-protein, RBD, and N-protein whereas currently approved vaccines in the US target only S-protein antigen"
Read More